Indivior Plc

Indivior is a global pharmaceutical company working to help change patients’ lives by pioneering life-transforming treatment for addiction and other serious mental illnesses.

Indivior manufactures and markets medicines for the treatment of moderate to severe opioid use disorder with a global portfolio in over 40 countries.

Indivior also markets medicine for the treatment of schizophrenia in adults in the United States and has a licensing agreement to bring this treatment to patients suffering from schizophrenia in Canada.